Search Results for: HCV

June 23, 2016June 23, 2016

New Hepatitis C Virus Study to Assess Host-Targeted Antiviral Drug Approach

Hepatitis C, News

Enanta Pharmaceuticals has begun dosing chronic hepatitis C virus (HCV) patients with its investigational drug EDP-494 as part of a proof-of-concept study designed to demonstrate the medicine’s efficacy in a subset of patients with ... Read more

June 16, 2016June 16, 2016

Highly Effective Interferon-Free Therapies for Hepatitis C Shown to Diminish Portal Vein Hypertension in Austrian Study

Hepatitis C, News

New interferon-free treatments for patients with hepatitis C were shown to decrease hypertension of the portal vein — which carries blood from the gut to the liver — decreasing the risk of ... Read more

June 7, 2016June 7, 2016

Economic Study Appeals for Lower Prices in New Hepatitis C Medicines

Hepatitis C, News

A recent economic study analyzed the high prices of new hepatitis C virus (HCV) medicines, prompting a wide debate about fairness and affordability. The study systematically compared prices of sofosbuvir ... Read more

June 2, 2016June 2, 2016

Free App Can Help Hep C Patients Fight Alcohol Addiction

Hepatitis C, News

Primrose Healthcare, a hepatitis C virus (HCV) management software company in Phoenix, Ariz., recently launched a mobile device alcohol application (app) designed to aid hepatitis C patients who struggle with ... Read more

May 19, 2016May 19, 2016

Treatment with New Hepatitis C Drugs Could Generate Billions in Savings Over 20 Years

Hepatitis C, News

New hepatitis C drugs cure the disease in a vast majority of patients, but the heavy price tag discourages their use. The debate on whether or not we can afford ... Read more

May 17, 2016May 17, 2016

People with Hepatitis C Infection 3 Times More Likely to Have Been Heavy Drinkers, Survey Finds

News

Excessive alcohol use increases the risk of morbidity and death in people infected with the hepatitis C virus (HCV), yet many of these patients were more likely to drink in excess — either now ... Read more

May 12, 2016May 12, 2016

Cost of Treating Hepatocellular Carcinoma in a Hepatitis C Cirrhosis Patient Now $175K, US Study Finds

News

The cost of treating hepatocellular carcinoma (HCC) in patients with hepatitis C cirrhosis is very high — more than $175,000 per patient, according to a study published in the journal Cancer, titled “Direct ... Read more

May 3, 2016May 3, 2016

Gene Involved in Lipid Metabolism Seen to Aid in Spread of Hepatitis C Virus

News

A gene whose mutations cause a rare human genetic disease associated with defects in lipid storage may be involved in the assembly and release of the hepatitis C virus (HCV), according ... Read more

April 28, 2016April 28, 2016

Hepatitis C Immunotherapy Clinical Trial Launched by Inovio, NCI, Mayo Clinic

News

Inovio Pharmaceuticals announced that a new Phase 1 clinical trial in chronic Hepatitis C virus (HCV) infections will assess its immunotherapy for Hepatitis C, INO-8000, in patients who are not receiving ... Read more

April 26, 2016April 26, 2016

Early and Effective Hepatitis C Treatment Seen to Reduce the Risk of Liver Cancer

News

Chronic hepatitis C that is treated and cured early — before cirrhosis develops and while patients are still young — reduces the risk of hepatocellular carcinoma (HCC), Baylor College of Medicine researchers ... Read more